Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Chison Medical Technologies (688358)
- 33.23
- -0.10-0.30%
Market Closed May 15 15:00 CST
3.73BMarket Cap30.83P/E (TTM)
33.87High32.84Low1.37MlotVolume33.73Open33.33Prev Close45.50MTurnover1.22%Turnover Ratio31.98P/E (Static)112.13MShares44.4852wk High2.62P/B3.72BFloat Cap25.9352wk Low40.00Limit Up111.98MShs Float67.69Historical High26.66Limit Down3.09%Range %17.52Historical Low1.30Dividend TTM33.33Avg Price772.06KlotAsk3.91%Div Yield TTM1Lot Size535.43KlotBid
Chison Medical Technologies (688358) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -0.34%127.28M | -7.02%435.81M | -5.27%343.17M | -4.61%236.15M | -9.16%127.71M | -3.13%468.7M | -9.85%362.25M | -16.47%247.57M | -14.87%140.6M | 27.04%483.84M |
| Operating revenue | -0.34%127.28M | -7.02%435.81M | -5.27%343.17M | -4.61%236.15M | -9.16%127.71M | -3.13%468.7M | -9.85%362.25M | -16.47%247.57M | -14.87%140.6M | 27.04%483.84M |
| Total operating cost | 5.12%87.57M | -1.93%321.43M | -7.95%244.79M | -1.88%161.87M | -6.39%83.31M | -4.84%327.75M | 3.39%265.92M | -5.84%164.98M | -20.25%88.99M | 18.16%344.44M |
| Operating cost | 0.49%49.63M | -7.34%178.25M | -6.81%137.88M | -5.95%92.94M | -10.80%49.39M | -5.14%192.38M | -8.79%147.96M | -17.40%98.81M | -15.21%55.37M | 30.79%202.81M |
| Operating tax surcharges | -36.19%385.77K | -38.26%2.5M | -49.37%1.83M | -52.10%1.18M | -45.36%604.54K | 0.53%4.05M | 33.65%3.61M | 63.57%2.46M | 128.67%1.11M | 26.84%4.02M |
| Operating expense | -15.34%10.88M | -0.88%54.51M | 4.03%41.07M | 10.54%27.92M | 3.35%12.85M | 11.50%55M | 11.82%39.48M | -2.75%25.26M | -5.85%12.43M | -1.91%49.33M |
| Administration expense | 7.93%8.39M | -2.71%36.61M | -11.80%23.97M | -17.26%15.53M | -1.38%7.77M | 7.73%37.63M | 15.03%27.17M | 11.96%18.77M | 28.02%7.88M | 4.90%34.93M |
| Financial expense | 58.09%-2M | 39.08%-24.94M | -17.46%-16.53M | 31.40%-13.31M | 36.10%-4.76M | -72.57%-40.94M | 45.03%-14.07M | 26.33%-19.4M | -214.38%-7.45M | 15.86%-23.73M |
| -Interest expense (Financial expense) | -15.62%59.02K | -18.17%309.91K | -48.38%153.46K | -55.85%92.22K | -63.57%69.94K | 5.99%378.74K | 32.78%297.3K | 43.33%208.88K | 174.36%191.99K | 225.54%357.35K |
| -Interest Income (Financial expense) | 15.49%-6.08M | -1.51%-31.67M | -16.00%-23.81M | -12.86%-16.67M | -2.75%-7.2M | -64.30%-31.2M | -65.55%-20.52M | -104.63%-14.77M | -583.94%-7M | -678.25%-18.99M |
| Research and development | 16.21%20.29M | -6.46%74.49M | -8.40%56.57M | -3.73%37.61M | -11.20%17.46M | 3.32%79.63M | 4.79%61.76M | 3.73%39.07M | -1.37%19.66M | -1.04%77.07M |
| Credit Impairment Loss | -88.74%-2.38M | 7.90%-1.82M | 9.03%-3.52M | 32.20%-2.09M | 37.40%-1.26M | 44.75%-1.97M | 38.85%-3.86M | 42.03%-3.08M | 32.88%-2.02M | -379.69%-3.57M |
| Asset Impairment Loss | -227.86%-1.87M | 5.42%-4.31M | -124.48%-2.19M | -276.51%-2.5M | -454.59%-571.8K | 17.58%-4.56M | -11.43%-974.95K | 22.78%-664.52K | 83.20%-103.1K | -28.87%-5.53M |
| Other net revenue | ||||||||||
| Fair value change income | ---- | ---- | -149.78%-131.31K | -64.79%95.76K | -71.06%141.98K | -94.16%170.98K | -86.63%263.78K | -87.51%272K | -76.59%490.53K | 314.37%2.93M |
| Invest income | -74.37%233.48K | -43.96%3.43M | -37.05%3.01M | -38.34%1.95M | -36.07%910.81K | -42.34%6.12M | -50.69%4.78M | -54.47%3.17M | -76.66%1.42M | -24.13%10.61M |
| Asset deal income | -100.57%-5.69K | -1.88%4.53M | 16.28%3.66M | 0.32%3.16M | --993.44K | 52.59%4.61M | 4,721.38%3.15M | 4,717.10%3.15M | ---- | 701.24%3.02M |
| Other revenue | 392.10%12.69M | -10.42%10.74M | -16.80%6.82M | -28.46%4.77M | 155.60%2.58M | -21.98%11.99M | -29.83%8.2M | 41.48%6.67M | -34.20%1.01M | -7.97%15.36M |
| Operating profit | 2.48%48.37M | -19.30%126.94M | -1.71%106.04M | -13.50%79.67M | -9.94%47.2M | -3.03%157.3M | -32.87%107.89M | -28.49%92.1M | -12.18%52.41M | 40.90%162.22M |
| Add:Non operating Income | 579,479.61%1.81M | 2,044.69%2.03M | 2,024.69%148.74K | 2,018.86%148.33K | -95.54%311.99 | -76.72%94.55K | 7.68%7K | 526,260.90%7K | --7K | 498.88%406.09K |
| Less:Non operating expense | -56.76%51.65K | -41.01%323.48K | 281.62%936.66K | 33.01%314.57K | 3,967.09%119.46K | 26.06%548.39K | 1,027.92%245.44K | 4,155.06%236.49K | 5,261.00%2.94K | 529.28%435.03K |
| Total profit | 6.47%50.12M | -17.98%128.65M | -2.23%105.25M | -13.47%79.5M | -10.18%47.08M | -3.30%156.85M | -33.01%107.65M | -28.67%91.88M | -12.17%52.41M | 40.88%162.19M |
| Less:Income tax cost | -24.98%4.1M | -25.66%12.15M | 22.59%11.33M | -6.89%9.81M | -20.50%5.46M | 3.99%16.34M | -52.01%9.24M | -37.44%10.53M | -4.04%6.87M | 69.20%15.71M |
| Net profit | 10.60%46.03M | -17.09%116.5M | -4.56%93.92M | -14.32%69.7M | -8.62%41.61M | -4.08%140.51M | -30.42%98.41M | -27.35%81.34M | -13.28%45.54M | 38.39%146.48M |
| Net profit from continuing operation | 10.60%46.03M | -17.09%116.5M | -4.56%93.92M | -14.32%69.7M | -8.62%41.61M | -4.08%140.51M | -30.42%98.41M | -27.35%81.34M | -13.28%45.54M | 38.39%146.48M |
| Net profit of parent company owners | 10.60%46.03M | -17.09%116.5M | -4.56%93.92M | -14.32%69.7M | -8.62%41.61M | -4.08%140.51M | -30.42%98.41M | -27.35%81.34M | -13.28%45.54M | 38.39%146.48M |
| Earning per share | ||||||||||
| Basic earning per share | 10.81%0.41 | -17.46%1.04 | -4.55%0.84 | -15.07%0.62 | -9.76%0.37 | -5.26%1.26 | -30.16%0.88 | -27.00%0.73 | -12.77%0.41 | 41.49%1.33 |
| Diluted earning per share | 10.81%0.41 | -17.46%1.04 | -4.55%0.84 | -15.07%0.62 | -9.76%0.37 | -5.26%1.26 | -30.16%0.88 | -27.00%0.73 | -12.77%0.41 | 41.49%1.33 |
| Other composite income | -1,894.03%-10.34M | -796.59%-13.41M | -28.57%-4.28M | -45,783.34%-1.53M | -9,364.56%-518.53K | 156,470.35%1.93M | -2,054.64%-3.33M | -79.32%3.36K | 102.20%5.6K | -30.84%1.23K |
| Other composite income of parent company owners | -1,894.03%-10.34M | -796.59%-13.41M | -28.57%-4.28M | -45,783.34%-1.53M | -9,364.56%-518.53K | 156,470.35%1.93M | ---3.33M | -79.32%3.36K | 102.20%5.6K | -30.84%1.23K |
| Total composite income | -13.16%35.69M | -27.62%103.09M | -5.72%89.64M | -16.21%68.16M | -9.77%41.1M | -2.77%142.43M | -32.85%95.08M | -27.36%81.35M | -12.85%45.55M | 38.39%146.48M |
| Total composite income of parent company owners | -13.16%35.69M | -27.62%103.09M | -5.72%89.64M | -16.21%68.16M | -9.77%41.1M | -2.77%142.43M | -32.85%95.08M | -27.36%81.35M | -12.85%45.55M | 38.39%146.48M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Rongcheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm